Page 90 - Read Online
P. 90
Page 12 of 12 Lorenzin et al. J Transl Genet Genom 2019;3:5. I https://doi.org/10.20517/jtgg.2019.01
cancer. Nat Commun 2017;8:48.
111. Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, et al. DNA-repair defects and olaparib in metastatic prostate cancer. N Engl J Med
2015;373:1697-708.
112. Wu YM, Cieslik M, Lonigro RJ, Vats P, Reimers MA, et al. Inactivation of CDK12 delineates a distinct immunogenic class of advanced
prostate cancer. Cell 2018;173:1770-82.e14.
